- Report
- January 2024
- 200 Pages
Global
From €4797EUR$5,000USD£4,132GBP
- Report
- October 2023
- 180 Pages
Global
From €4701EUR$4,900USD£4,049GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €2399EUR$2,500USD£2,066GBP
- Clinical Trials
- April 2024
- 240 Pages
Global
From €2878EUR$3,000USD£2,479GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1919EUR$2,000USD£1,653GBP
- Clinical Trials
- April 2024
- 75 Pages
Global
From €1439EUR$1,500USD£1,240GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1919EUR$2,000USD£1,653GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1919EUR$2,000USD£1,653GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1919EUR$2,000USD£1,653GBP
- Report
- January 2024
- 189 Pages
Global
From €7196EUR$7,500USD£6,198GBP
- Report
- October 2023
- 190 Pages
Global
From €4701EUR$4,900USD£4,049GBP
- Report
- October 2023
- 145 Pages
Global
From €3022EUR$3,150USD£2,603GBP
- Report
- March 2024
- 199 Pages
Global
From €3237EUR$3,374USD£2,788GBP
€3597EUR$3,749USD£3,098GBP
- Report
- March 2024
- 186 Pages
Global
From €3237EUR$3,374USD£2,788GBP
€3597EUR$3,749USD£3,098GBP
- Report
- February 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,132GBP
- Report
- January 2024
- 200 Pages
Global
From €4797EUR$5,000USD£4,132GBP
- Report
- May 2024
- 179 Pages
Global
From €4749EUR$4,950USD£4,091GBP
- Report
- February 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,132GBP
- Report
- February 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,132GBP
- Report
- February 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,132GBP
The Kidney Disease Drug market is a subset of the larger Liver and Kidney Disorders Drugs market. These drugs are used to treat a variety of conditions, including chronic kidney disease, acute kidney injury, and end-stage renal disease. They can also be used to treat other conditions such as hypertension, diabetes, and anemia. These drugs are typically prescribed by a physician and can be taken orally or intravenously. They can also be administered through dialysis or other treatments.
The Kidney Disease Drug market is highly competitive, with many companies offering a variety of products. These companies include major pharmaceutical companies, as well as smaller, specialized companies. Some of the major players in the market include Pfizer, Merck, Novartis, and Sanofi. Other companies include AbbVie, AstraZeneca, Bristol-Myers Squibb, and GlaxoSmithKline. Show Less Read more